Literature DB >> 25742071

Generation of plasmid vectors expressing FLAG-tagged proteins under the regulation of human elongation factor-1α promoter using Gibson assembly.

Petar N Grozdanov1, Clinton C MacDonald2.   

Abstract

Gibson assembly (GA) cloning offers a rapid, reliable, and flexible alternative to conventional DNA cloning methods. We used GA to create customized plasmids for expression of exogenous genes in mouse embryonic stem cells (mESCs). Expression of exogenous genes under the control of the SV40 or human cytomegalovirus promoters diminishes quickly after transfection into mESCs. A remedy for this diminished expression is to use the human elongation factor-1 alpha (hEF1α) promoter to drive gene expression. Plasmid vectors containing hEF1α are not as widely available as SV40- or CMV-containing plasmids, especially those also containing N-terminal 3xFLAG-tags. The protocol described here is a rapid method to create plasmids expressing FLAG-tagged CstF-64 and CstF-64 mutant under the expressional regulation of the hEF1α promoter. GA uses a blend of DNA exonuclease, DNA polymerase and DNA ligase to make cloning of overlapping ends of DNA fragments possible. Based on the template DNAs we had available, we designed our constructs to be assembled into a single sequence. Our design used four DNA fragments: pcDNA 3.1 vector backbone, hEF1α promoter part 1, hEF1α promoter part 2 (which contained 3xFLAG-tag purchased as a double-stranded synthetic DNA fragment), and either CstF-64 or specific CstF-64 mutant. The sequences of these fragments were uploaded to a primer generation tool to design appropriate PCR primers for generating the DNA fragments. After PCR, DNA fragments were mixed with the vector containing the selective marker and the GA cloning reaction was assembled. Plasmids from individual transformed bacterial colonies were isolated. Initial screen of the plasmids was done by restriction digestion, followed by sequencing. In conclusion, GA allowed us to create customized plasmids for gene expression in 5 days, including construct screens and verification.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25742071      PMCID: PMC4354628          DOI: 10.3791/52235

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  21 in total

1.  Two distinct forms of the 64,000 Mr protein of the cleavage stimulation factor are expressed in mouse male germ cells.

Authors:  A M Wallace; B Dass; S E Ravnik; V Tonk; N A Jenkins; D J Gilbert; N G Copeland; C C MacDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

2.  Lentivirus vectors incorporating the immunoglobulin heavy chain enhancer and matrix attachment regions provide position-independent expression in B lymphocytes.

Authors:  Carolyn Lutzko; Dinithi Senadheera; Dianne Skelton; Denise Petersen; Donald B Kohn
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

3.  Assignment of human elongation factor 1alpha genes: EEF1A maps to chromosome 6q14 and EEF1A2 to 20q13.3.

Authors:  A Lund; S M Knudsen; H Vissing; B Clark; N Tommerup
Journal:  Genomics       Date:  1996-09-01       Impact factor: 5.736

4.  Total synthesis of a functional designer eukaryotic chromosome.

Authors:  Narayana Annaluru; Héloïse Muller; Leslie A Mitchell; Sivaprakash Ramalingam; Giovanni Stracquadanio; Sarah M Richardson; Jessica S Dymond; Zheng Kuang; Lisa Z Scheifele; Eric M Cooper; Yizhi Cai; Karen Zeller; Neta Agmon; Jeffrey S Han; Michalis Hadjithomas; Jennifer Tullman; Katrina Caravelli; Kimberly Cirelli; Zheyuan Guo; Viktoriya London; Apurva Yeluru; Sindurathy Murugan; Karthikeyan Kandavelou; Nicolas Agier; Gilles Fischer; Kun Yang; J Andrew Martin; Murat Bilgel; Pavlo Bohutski; Kristin M Boulier; Brian J Capaldo; Joy Chang; Kristie Charoen; Woo Jin Choi; Peter Deng; James E DiCarlo; Judy Doong; Jessilyn Dunn; Jason I Feinberg; Christopher Fernandez; Charlotte E Floria; David Gladowski; Pasha Hadidi; Isabel Ishizuka; Javaneh Jabbari; Calvin Y L Lau; Pablo A Lee; Sean Li; Denise Lin; Matthias E Linder; Jonathan Ling; Jaime Liu; Jonathan Liu; Mariya London; Henry Ma; Jessica Mao; Jessica E McDade; Alexandra McMillan; Aaron M Moore; Won Chan Oh; Yu Ouyang; Ruchi Patel; Marina Paul; Laura C Paulsen; Judy Qiu; Alex Rhee; Matthew G Rubashkin; Ina Y Soh; Nathaniel E Sotuyo; Venkatesh Srinivas; Allison Suarez; Andy Wong; Remus Wong; Wei Rose Xie; Yijie Xu; Allen T Yu; Romain Koszul; Joel S Bader; Jef D Boeke; Srinivasan Chandrasegaran
Journal:  Science       Date:  2014-03-27       Impact factor: 47.728

5.  In-fusion® cloning with vaccinia virus DNA polymerase.

Authors:  Chad R Irwin; Andrew Farmer; David O Willer; David H Evans
Journal:  Methods Mol Biol       Date:  2012

6.  Expression of genes transferred to haemopoietic stem cells by recombinant retroviruses.

Authors:  D D Bowtell; G R Johnson; A Kelso; S Cory
Journal:  Mol Biol Med       Date:  1987-08

7.  High-throughput sequencing of RNA isolated by cross-linking and immunoprecipitation (HITS-CLIP) to determine sites of binding of CstF-64 on nascent RNAs.

Authors:  Petar N Grozdanov; Clinton C Macdonald
Journal:  Methods Mol Biol       Date:  2014

8.  CstF-64 supports pluripotency and regulates cell cycle progression in embryonic stem cells through histone 3' end processing.

Authors:  Bradford A Youngblood; Petar N Grozdanov; Clinton C MacDonald
Journal:  Nucleic Acids Res       Date:  2014-06-23       Impact factor: 16.971

9.  Enzymatic assembly of overlapping DNA fragments.

Authors:  Daniel G Gibson
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

10.  Np95 interacts with de novo DNA methyltransferases, Dnmt3a and Dnmt3b, and mediates epigenetic silencing of the viral CMV promoter in embryonic stem cells.

Authors:  Daniela Meilinger; Karin Fellinger; Sebastian Bultmann; Ulrich Rothbauer; Ian Marc Bonapace; Wolfgang E F Klinkert; Fabio Spada; Heinrich Leonhardt
Journal:  EMBO Rep       Date:  2009-10-02       Impact factor: 8.807

View more
  2 in total

1.  Design of the lentivirus-driven sustained LR12 delivery system for TREM-1 inhibition for palliating atherosclerosis.

Authors:  Finosh G Thankam; David J Sanchez; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2022-01-10       Impact factor: 3.396

2.  A protocol for custom CRISPR Cas9 donor vector construction to truncate genes in mammalian cells using pcDNA3 backbone.

Authors:  Neftali Vazquez; Lilia Sanchez; Rebecca Marks; Eduardo Martinez; Victor Fanniel; Alma Lopez; Andrea Salinas; Itzel Flores; Jesse Hirschmann; Robert Gilkerson; Erin Schuenzel; Robert Dearth; Reginald Halaby; Wendy Innis-Whitehouse; Megan Keniry
Journal:  BMC Mol Biol       Date:  2018-03-14       Impact factor: 2.946

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.